Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT03113643
Brief Title: SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

First Submitted : April 10, 2017
First Submitted that Met QC Criteria : April 10, 2017
First Posted : April 13, 2017

Last Update Submitted that Met QC Criteria : September 16, 2019
Last Update Posted : September 18, 2019